Levodril (Levodropropizine)

• Levodropropizine is an antitussive that acts on the peripheral cough reflex pathway.
• Dry cough: reduces the frequency and intensity of non‑productive cough episodes.
• Cough: provides symptomatic relief of acute cough in adults and children.
• Irritant cough: alleviates cough triggered by throat irritation.

• Levodropropizine exerts its antitussive effect by acting peripherally on sensory nerve endings in the respiratory tract. It inhibits the activation of cough receptors, thereby decreasing the sensitivity of the cough reflex without affecting the central nervous system. This peripheral blockade leads to a reduction in cough frequency and severity while preserving normal respiratory function.

Levodropropizine is generally well tolerated, but adverse reactions can occur.

Common Side Effects

• Nausea: mild to moderate stomach upset.
• Diarrhea: loose stools occurring intermittently.
• Dizziness: transient light‑headedness.
• Headache: mild frontal or occipital pain.
• Taste alteration: temporary metallic or bitter taste.
• Fatigue: mild feeling of tiredness.

Serious or Rare Side Effects

• Allergic reaction: rash, itching, swelling, or difficulty breathing.
• Hepatic dysfunction: elevated liver enzymes or jaundice.
• Severe gastrointestinal bleeding: uncommon but possible.
• Anaphylaxis: rapid onset of systemic allergic response.
• Cardiac arrhythmia: rare irregular heartbeat.
• Severe skin reactions: Stevens‑Johnson syndrome or toxic epidermal necrolysis.

• When prescribing Levodropropizine, clinicians should consider the following safety measures.
• Pregnancy: use only if the potential benefit justifies the potential risk to the fetus.
• Breastfeeding: assess risk versus benefit, as the drug may be excreted in milk.
• Renal impairment: dose adjustment may be required in severe cases.
• Hepatic impairment: monitor liver function tests during therapy.
• Concomitant CNS depressants: observe for additive sedation, although central effects are minimal.
• Store at ambient temperature: keep below 25°C, retain in original packaging, and protect from moisture.

Levodropropizine may interact with other medicines; awareness of the interaction level helps guide clinical decisions.

Major Interactions (Avoid)

• Monoamine oxidase inhibitors (MAOIs): risk of heightened serotonergic effects.
• Strong CYP450 inhibitors: may increase plasma concentrations of levodropropizine.

Moderate Interactions (Monitor Closely)

• Antihistamines: possible additive antitussive effect leading to excessive cough suppression.
• Sedative agents: monitor for enhanced drowsiness.
• Other peripheral antitussives: avoid cumulative dosing.
• Herbal products containing menthol: may potentiate local irritation.
• Acid‑reducing agents: could alter absorption profile.